20th Aug 2024 13:15
Renalytix PLC - London-based in vitro diagnostics for kidney disease - Shares fall as Renalytix ends the formal sale process it launched back in March without an offer. Based on its discussions to date, the board doesn't think there is a "realistic prospect" of a takeover offer in the "near term". Renalytix says it is in talks with "key stakeholders" in the company about "a suitable capital structure and funding". Cash runway extends into the fourth quarter of this year based on its cash position of USD4.7 million on June 30. Read More